The novel and selective α4β2 agonist, SUVN-911 enhances acetylcholine levels in frontoparietal cortex
Alzheimer's & dementia: the journal of the Alzheimer's Association (impact factor: 5.9). 01/2010; 6(4):S563. pp.S563
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.